HCW Biologics Inc.
HCWB
$6.78
-$0.2511-3.57%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -30.02M | -37.33M | -38.37M | -27.39M | -24.99M |
| Total Depreciation and Amortization | 1.18M | 776.40K | 925.50K | 1.08M | 1.14M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.01M | 6.23M | 6.17M | 6.09M | 5.99M |
| Change in Net Operating Assets | 13.60M | 15.04M | 13.32M | -2.25M | -4.64M |
| Cash from Operations | -14.23M | -15.29M | -17.95M | -22.48M | -22.51M |
| Capital Expenditure | -261.60K | -3.86M | -4.46M | -6.03M | -6.20M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 0.00 | 10.00M | 10.00M | 10.00M |
| Cash from Investing | -261.60K | -3.86M | 5.54M | 3.97M | 3.80M |
| Total Debt Issued | 6.91M | 6.53M | 3.70M | 1.75M | -- |
| Total Debt Repaid | -119.40K | -117.70K | -97.10K | -68.00K | -38.30K |
| Issuance of Common Stock | 9.42M | 2.52M | 2.52M | 2.52M | 23.70K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -638.00K | -- | -- | -- | -- |
| Cash from Financing | 15.57M | 8.93M | 6.12M | 4.21M | -14.60K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.08M | -10.22M | -6.29M | -14.31M | -18.73M |